Log In
Print
BCIQ
Print
Print this Print this
 

Co-Dio, Co-Diovan, Co-Tareg, valsartan/hydrochlorothiazide (Diovan HCT)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCombination of angiotensin receptor blocker (ARB) valsartan and diuretic hydrochlorothiazide (HCTZ)
Molecular Target Angiotensin receptor
Mechanism of ActionAngiotensin receptor blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsSecond-line treatment for hypertension; Treat hypertension; Treat hypertension as a first-line therapy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today